Troglitazone, a peroxisome proliferator-activated receptor γ ligand, induces growth inhibition and apoptosis of HepG2 human liver cancer cells

Figure 6 Survivin was present predominantly in the nucleus in untreated cells ( A: original magnification, × 400) as demonstrated by immunocytochemistry. After exposure of HepG2 cells to 30 &mgr;mol/L troglitazone for 24 h, survivin incompletely translocated from the nucleus to the cytoplasma ( B: original magnification, × 400).